Development of immunity following financial incentives for hepatitis B vaccination among people who inject drugs: A randomized controlled trial
- 1 January 2016
- journal article
- research article
- Published by Elsevier in Journal of Clinical Virology
- Vol. 74, 66-72
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Global epidemiology of hepatitis C virus infection: New estimates of age-specific antibody to HCV seroprevalenceHepatology, 2013
- Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviewsThe Lancet, 2011
- The impact of a new universal infant and school-based adolescent hepatitis B vaccination program in AustraliaVaccine, 2007
- Poor validity of self-reported HBV vaccination among young heroin users in Spain supports the policy “don’t ask, draw a blood sample, vaccinate and try to schedule another visit”Journal of Clinical Virology, 2007
- Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage studyThe Lancet, 2006
- The impact of hepatitis B vaccination in a Western country: Recall of vaccination and serological status in Australian adultsVaccine, 2006
- Poor Validity of Self‐Reported Hepatitis B Virus Infection and Vaccination Status among Young Drug UsersClinical Infectious Diseases, 2004
- Hepatitis B Virus Immunization Among Young Injection Drug Users in San Francisco, Calif: The UFO StudyAmerican Journal of Public Health, 2003
- Immunoresponse to hepatitis B vaccination and adherence campaign among injecting drug usersVaccine, 1997
- Immune response to hepatitis B vaccine in parenteral drug abusersVaccine, 1992